Prophylactic effect of administration of human gamma globulins in a mouse model of tuberculosis

Tuberculosis - Tập 89 Số 3 - Trang 218-220 - 2009
Nesty Olivares1, Alina Puig1, Diana Aguilar2, Aniel Moya1, Armando Cádiz1, Oscar Otero1, Luís Izquierdo1, Gustavo Falero1, Rosa L. Solís1, Héctor Orozco2, María E. Sarmiento1, Mohd Nor Norazmi3, Rogelio Hernández‐Pando2, Armando Acosta1
1Department of Molecular Biology, Finlay Institute, Ave 27 No. 19805, La Lisa, Havana City, AP 16017, CP 11600, Cuba
2Experimental Pathology Section, Department of Pathology, National Institute of Medical Sciences and Nutrition “Salvador Zubiràn”, Mexico
3School of Health Sciences, Univesiti Sains Malaysia, 16150 Kubang Kerian, Kelantan, Malaysia

Tóm tắt

Từ khóa


Tài liệu tham khảo

Norazmi, 2005, Recent advances in tuberculosis vaccine development, Curr Respir Med Rev, 1, 109, 10.2174/1573398054023000

Williams, 2004, Passive protection with immunoglobulin A antibodies against tuberculous early infection of the lung, Immunology, 111, 328, 10.1111/j.1365-2567.2004.01809.x

Reljic, 2006, Intranasal IFN extends passive IgA antibody protection of mice against Mycobacterium tuberculosis lung infection, Clin Exp Immunol, 143, 467, 10.1111/j.1365-2249.2006.03012.x

Roy, 2005, Therapeutic efficacy of high-dose intravenous immunoglobulin in Mycobacterium tuberculosis infection in mice, Infect Immun, 73, 6101, 10.1128/IAI.73.9.6101-6109.2005

Olivares, 2006, The effect of the administration of human gamma globulins in a model of BCG infection in mice, Tuberculosis, 86, 268, 10.1016/j.tube.2006.01.006

Cadiz, 1998, Modifications of the Cohn's method of alcoholic fractionment for production of immunoglobulins, Vaccimonitor, 5, 5

Glatman-Freedman, 1998, Serum therapy for tuberculosis revisited reappraisal of the role of antibody-mediated immunity against Mycobacterium tuberculosis, Clin Microbiol Rev, 11, 514, 10.1128/CMR.11.3.514

Glatman-Freedman, 2003, Advances in antibody-mediated immunity against Mycobacterium tuberculosis: implications for a novel vaccine strategy, FEMS Immunol Med Microbiol, 39, 9, 10.1016/S0928-8244(03)00172-X

Zitrin, 1957, Preliminary experiment on passive transfer of protective humoral antibodies in tuberculosis, Am Rev Tuberc Pulm Dis, 76, 256

Igietseme, 2004, Antibody regulation of T cell immunity: implications for vaccine strategies against intracellular pathogens, Expert Rev Vaccines, 3, 23, 10.1586/14760584.3.1.23

Pethe, 2001, The heparin-binding hemagglutinin of M. tuberculosis is required for extra pulmonary dissemination, Nature, 412, 190, 10.1038/35084083

Teitelbaum, 1998, A mAb recognizing a surface antigen of Mycobacterium tuberculosis enhances host survival, Proc Natl Acad Sci U S A, 95, 15688, 10.1073/pnas.95.26.15688

Guirado, 2006, Passive serum therapy with polyclonal antibodies against Mycobacterium tuberculosis protects against post-chemotherapy relapse of tuberculosis infection in SCID mice, Microbes Infect, 8, 1252, 10.1016/j.micinf.2005.12.004

Cardona, 2006, RUTI: a new chance to shorten the treatment of latent tuberculosis infection, Tuberculosis (Edinb), 86, 273, 10.1016/j.tube.2006.01.024

Chambers, 2004, Antibody bound to the surface antigen MPB83 of Mycobacterium bovis enhances survival against high dose and low dose challenge, FEMS Immunol Med Microbiol, 41, 93, 10.1016/j.femsim.2004.01.004

Glatman-Freedman, 2006, The role of antibody-mediated immunity in defence against Mycobacterium tuberculosis: advances toward a novel vaccine strategy, Tuberculosis (Edinb), 86, 191, 10.1016/j.tube.2006.01.008

Nimmerjahn, 2008, Anti-inflammatory actions of intravenous immunoglobulin, Annu Rev Immunol, 26, 513, 10.1146/annurev.immunol.26.021607.090232